Tokyo Tape
Sign in
← Ono Pharmaceutical

Annual report

4528.TEDINET S100QU2A
Period2022-04-01 → 2023-03-31
Filed2023-06-23
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 157
MetricValuePeriodScopeSource row
Revenue¥447.2bn2022-04-01 → 2023-03-31Cons.Revenue IFRS
Revenue¥361.4bn2021-04-01 → 2022-03-31Cons.Revenue IFRS
Revenue¥309.3bn2020-04-01 → 2021-03-31dCons.Revenue IFRS (5-year summary)
Revenue¥292.4bn2019-04-01 → 2020-03-31dCons.Revenue IFRS (5-year summary)
Revenue¥288.6bn2018-04-01 → 2019-03-31dCons.Revenue IFRS (5-year summary)
Operating income¥142.0bn2022-04-01 → 2023-03-31Cons.Operating profit loss IFRS
Operating income¥103.2bn2021-04-01 → 2022-03-31Cons.Operating profit loss IFRS
Profit before tax¥143.5bn2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS
Profit before tax¥105.0bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS
Profit before tax¥100.9bn2020-04-01 → 2021-03-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥79.7bn2019-04-01 → 2020-03-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥65.1bn2018-04-01 → 2019-03-31dCons.Profit loss before tax IFRS (5-year summary)
Net income (owners)¥112.7bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥80.5bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥75.4bn2020-04-01 → 2021-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥59.7bn2019-04-01 → 2020-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥51.5bn2018-04-01 → 2019-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income¥112.9bn2022-04-01 → 2023-03-31Cons.Profit loss IFRS
Net income¥80.7bn2021-04-01 → 2022-03-31Cons.Profit loss IFRS
Total assets¥882.4bnat 2023-03-31Cons.Assets IFRS
Total assets¥739.2bnat 2022-03-31Cons.Assets IFRS
Total assets¥745.4bnat 2021-03-31dCons.Total assets IFRS (5-year summary)
Total assets¥673.4bnat 2020-03-31dCons.Total assets IFRS (5-year summary)
Total assets¥655.1bnat 2019-03-31dCons.Total assets IFRS (5-year summary)
Total liabilities¥134.6bnat 2023-03-31Cons.Liabilities IFRS
Total liabilities¥77.5bnat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥747.8bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥661.7bnat 2022-03-31Cons.Equity IFRS
Net assets / equity¥639.7bnat 2021-03-31dCons.Equity IFRS
Equity (owners)¥741.9bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥655.9bnat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥634.1bnat 2021-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥562.5bnat 2020-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥557.4bnat 2019-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥96.1bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥69.1bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥61.0bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Cash & equivalents¥69.0bnat 2020-03-31dCons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥60.0bnat 2019-03-31dCons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow¥159.6bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥61.8bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥74.0bn2020-04-01 → 2021-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥74.2bn2019-04-01 → 2020-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥66.8bn2018-04-01 → 2019-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Investing cash flow−¥100.3bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow¥6.0bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥57.6bn2020-04-01 → 2021-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥10.2bn2019-04-01 → 2020-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥49.8bn2018-04-01 → 2019-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Financing cash flow−¥32.5bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥60.2bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥24.8bn2020-04-01 → 2021-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥54.7bn2019-04-01 → 2020-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥22.3bn2018-04-01 → 2019-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
EPS (basic)¥230.852022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥162.192021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥151.112020-04-01 → 2021-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥118.472019-04-01 → 2020-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥100.252018-04-01 → 2019-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (diluted)¥230.792022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥162.162021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥151.092020-04-01 → 2021-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥118.452019-04-01 → 2020-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥100.242018-04-01 → 2019-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
Net assets per share¥1,519.19at 2023-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥1,343.4at 2022-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥1,270.45at 2021-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥1,126.95at 2020-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥1,084.08at 2019-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Equity ratio84.1%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio88.7%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio85.1%at 2021-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio83.5%at 2020-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio85.1%at 2019-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
ROE16.1%2022-04-01 → 2023-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE12.5%2021-04-01 → 2022-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE12.6%2020-04-01 → 2021-03-31dCons.Rate of return on equity IFRS (5-year summary)
ROE10.7%2019-04-01 → 2020-03-31dCons.Rate of return on equity IFRS (5-year summary)
ROE9.5%2018-04-01 → 2019-03-31dCons.Rate of return on equity IFRS (5-year summary)
Employees3,761at 2023-03-31Cons.Number of employees
Employees3,687at 2022-03-31Cons.Number of employees
Employees3,607at 2021-03-31dCons.Number of employees
Employees3,560at 2020-03-31dCons.Number of employees
Employees3,555at 2019-03-31dCons.Number of employees
Revenue¥441.2bn2022-04-01 → 2023-03-31StandaloneNet sales
Revenue¥357.0bn2021-04-01 → 2022-03-31StandaloneNet sales
Revenue¥305.2bn2020-04-01 → 2021-03-31dStandaloneNet sales (5-year summary)
Revenue¥286.2bn2019-04-01 → 2020-03-31dStandaloneNet sales (5-year summary)
Revenue¥286.4bn2018-04-01 → 2019-03-31dStandaloneNet sales (5-year summary)
Operating income¥152.0bn2022-04-01 → 2023-03-31StandaloneOperating income
Operating income¥119.9bn2021-04-01 → 2022-03-31StandaloneOperating income
Ordinary income¥150.8bn2022-04-01 → 2023-03-31StandaloneOrdinary income
Ordinary income¥121.1bn2021-04-01 → 2022-03-31StandaloneOrdinary income
Ordinary income¥86.8bn2020-04-01 → 2021-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥70.8bn2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥58.3bn2018-04-01 → 2019-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥148.2bn2022-04-01 → 2023-03-31StandaloneIncome before income taxes
Profit before tax¥124.4bn2021-04-01 → 2022-03-31StandaloneIncome before income taxes
Net income¥117.2bn2022-04-01 → 2023-03-31StandaloneProfit loss
Net income¥94.6bn2021-04-01 → 2022-03-31StandaloneProfit loss
Net income¥76.9bn2020-04-01 → 2021-03-31dStandaloneNet income loss (5-year summary)
Net income¥69.3bn2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Net income¥55.7bn2018-04-01 → 2019-03-31dStandaloneNet income loss (5-year summary)
Total assets¥804.6bnat 2023-03-31StandaloneAssets
Total assets¥661.9bnat 2022-03-31StandaloneAssets
Total assets¥669.6bnat 2021-03-31dStandaloneTotal assets (5-year summary)
Total assets¥599.4bnat 2020-03-31dStandaloneTotal assets (5-year summary)
Total assets¥591.4bnat 2019-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥119.0bnat 2023-03-31StandaloneLiabilities
Total liabilities¥62.7bnat 2022-03-31StandaloneLiabilities
Net assets / equity¥685.6bnat 2023-03-31StandaloneNet assets
Net assets / equity¥599.2bnat 2022-03-31StandaloneNet assets
Net assets / equity¥574.6bnat 2021-03-31dStandaloneNet assets
Net assets / equity¥507.7bnat 2020-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥507.1bnat 2019-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥147.0bnat 2023-03-31StandaloneCash and deposits
Cash and deposits¥102.6bnat 2022-03-31StandaloneCash and deposits
EPS (basic)¥239.962022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥190.512021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥154.12020-04-01 → 2021-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥137.592019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥108.392018-04-01 → 2019-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥239.942022-04-01 → 2023-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥190.492021-04-01 → 2022-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥154.082020-04-01 → 2021-03-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥137.572019-04-01 → 2020-03-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥108.382018-04-01 → 2019-03-31dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥702022-04-01 → 2023-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥562021-04-01 → 2022-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥502020-04-01 → 2021-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥452019-04-01 → 2020-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥452018-04-01 → 2019-03-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥1,403.84at 2023-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥1,226.79at 2022-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥1,150.68at 2021-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥1,016.83at 2020-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥985.91at 2019-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio85.2%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio90.5%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio85.8%at 2021-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio84.7%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio85.7%at 2019-03-31dStandaloneEquity to asset ratio (5-year summary)
ROE18.2%2022-04-01 → 2023-03-31StandaloneRate of return on equity (5-year summary)
ROE16.1%2021-04-01 → 2022-03-31StandaloneRate of return on equity (5-year summary)
ROE14.2%2020-04-01 → 2021-03-31dStandaloneRate of return on equity (5-year summary)
ROE13.7%2019-04-01 → 2020-03-31dStandaloneRate of return on equity (5-year summary)
ROE11.3%2018-04-01 → 2019-03-31dStandaloneRate of return on equity (5-year summary)
Shares issued517,425,000at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued528,341,000at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued528,341,000at 2021-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued528,341,000at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued543,341,000at 2019-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees3,381at 2023-03-31StandaloneNumber of employees
Employees3,354at 2022-03-31StandaloneNumber of employees
Employees3,319at 2021-03-31dStandaloneNumber of employees
Employees3,287at 2020-03-31dStandaloneNumber of employees
Employees3,284at 2019-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 2
SegmentItemPeriodValue
Pharmaceutical Productsreportable segmentemployeesat 2023-03-313761 pure
Pharmaceutical Productsreportable segmentemployeesat 2023-03-313381 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,909
ItemContextValueUnit
Finance income IFRSCurrentYearDuration2478000000JPY
Finance costs IFRSPrior1YearDuration874000000JPY
Finance costs IFRSCurrentYearDuration913000000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1YearDuration-6000000JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentYearDuration4000000JPY
Profit loss before tax IFRSPrior1YearDuration105025000000JPY
Profit loss before tax IFRSCurrentYearDuration143532000000JPY
Income tax expense IFRSPrior1YearDuration24340000000JPY
Income tax expense IFRSCurrentYearDuration30619000000JPY
Profit loss IFRSPrior1YearDuration80684000000JPY
Profit loss IFRSCurrentYearDuration112913000000JPY
Profit loss attributable to owners of parent IFRSPrior1YearDuration80519000000JPY
Profit loss attributable to owners of parent IFRSCurrentYearDuration112723000000JPY
Profit loss attributable to non controlling interests IFRSPrior1YearDuration166000000JPY
Profit loss attributable to non controlling interests IFRSCurrentYearDuration190000000JPY
Profit loss IFRSPrior1YearDuration80684000000JPY
Profit loss IFRSCurrentYearDuration112913000000JPY
Basic earnings loss per share IFRSPrior1YearDuration162.19
Basic earnings loss per share IFRSCurrentYearDuration230.85
Diluted earnings loss per share IFRSPrior1YearDuration162.16
Diluted earnings loss per share IFRSCurrentYearDuration230.79
Profit loss IFRSPrior1YearDuration80684000000JPY
Profit loss IFRSCurrentYearDuration112913000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YearDuration-2094000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYearDuration2518000000JPY
Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YearDuration199000000JPY
Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYearDuration-114000000JPY
Share of net changes in the fair value of financial assets measured through other comprehensive income of entities accounted for using equity method net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YearDuration2000000JPY
Share of net changes in the fair value of financial assets measured through other comprehensive income of entities accounted for using equity method net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYearDuration2000000JPY
Total of items that will not be reclassified to profit or loss oci IFRSPrior1YearDuration-1893000000JPY
Total of items that will not be reclassified to profit or loss oci IFRSCurrentYearDuration2406000000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSPrior1YearDuration814000000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSCurrentYearDuration472000000JPY
Total of items that may be reclassified to profit or loss oci IFRSPrior1YearDuration814000000JPY
Total of items that may be reclassified to profit or loss oci IFRSCurrentYearDuration472000000JPY
Other comprehensive income IFRSPrior1YearDuration-1079000000JPY
Other comprehensive income IFRSCurrentYearDuration2878000000JPY
Comprehensive income IFRSPrior1YearDuration79606000000JPY
Comprehensive income IFRSCurrentYearDuration115791000000JPY
Comprehensive income attributable to owners of parent IFRSPrior1YearDuration79444000000JPY
Comprehensive income attributable to owners of parent IFRSCurrentYearDuration115608000000JPY
Comprehensive income attributable to non controlling interests IFRSPrior1YearDuration161000000JPY
Comprehensive income attributable to non controlling interests IFRSCurrentYearDuration182000000JPY
Comprehensive income IFRSPrior1YearDuration79606000000JPY
Comprehensive income IFRSCurrentYearDuration115791000000JPY
Equity IFRSPrior2YearInstant_ShareCapitalIFRSMember17358000000JPY
Equity IFRSPrior2YearInstant_CapitalSurplusIFRSMember17231000000JPY
Equity IFRSPrior2YearInstant_TreasurySharesIFRSMember-44705000000JPY
Equity IFRSPrior2YearInstant_OtherComponentsOfEquityIFRSMember62299000000JPY
Equity IFRSPrior2YearInstant_RetainedEarningsIFRSMember581950000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 21 of 21 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2023-03-31pass
balance sheet identitynon_consolidated 2022-03-31pass rounding
balance sheet identitynon_consolidated 2023-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2021-03-31pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2023-03-31pass
statement vs summary · revenueconsolidated 2021-04-01/2022-03-31pass
statement vs summary · revenueconsolidated 2022-04-01/2023-03-31pass
statement vs summary · revenuenon_consolidated 2021-04-01/2022-03-31pass
statement vs summary · revenuenon_consolidated 2022-04-01/2023-03-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass